First Trust Nasdaq Pharmaceuticals ETF
FTXH
FTXH
7 hedge funds and large institutions have $1.08M invested in First Trust Nasdaq Pharmaceuticals ETF in 2018 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
Holders
7
Holders Change
+2
Holders Change %
+40%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Jane Street
New York
|
$983K |
| 2 |
SMFS
2
Squar Milner Financial Services
Irvine,
California
|
$13K |
| 3 |
3
Royal Bank of Canada
Toronto,
Ontario, Canada
|
$21K |
| 4 |
4
UBS Group
Zurich,
Switzerland
|
$6K |
Top Sellers
| 1 |
TRCT
1
Tower Research Capital (TRC)
New York
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| $983K | 45,294 | +45,294 | New |
|
2
Bank of America
Charlotte,
North Carolina
| $43K | 2,000 | – | – |
|
|
3
Royal Bank of Canada
Toronto,
Ontario, Canada
| $21K | 957 | +400 | +72% |
|
|
SMFS
4
Squar Milner Financial Services
Irvine,
California
| $13K | 590 | +590 | New |
|
|
LTFS
5
Ladenburg Thalmann Financial Services
Miami,
Florida
| $8K | 394 | – | – |
|
|
6
UBS Group
Zurich,
Switzerland
| $6K | 266 | +266 | New |
|
|
APA
7
American Portfolios Advisors
Holbrook,
New York
| $5.42K | 250 | – | – |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| – | – | -46 | Closed |
|